Your implementation of your solution will continue as planned with the same team, same product and same service.

The Crescendo product will continue to be developed and supported.

The AppointMate product will continue to be supported.

AlayaCare and the Delta Health team will be working together to create a best-of-breed solution by integrating highly-valued AppointMate and Crescendo features into the AlayaCare product. Over time, AlayaCare will offer the most end-to-end and robust home health, hospice, and community solutions and will encourage Delta Health customers to continue to trust AlayaCare as a partner moving forward.

All current roadmaps and client commitments will be considered as our teams work together to develop a comprehensive and seamless product integration plan.

Your key contacts and staff will remain the same. The AlayaCare team is looking forward to welcoming the Delta Health team to our family as they continue to support your organization.

There will be no impact on the Delta Health or AlayaCare subscription or professional services costs as a result of the acquisition.

No changes will be made to your SLA, you’ll receive the same great support you’re used to as specified by both AlayaCare and Delta Health.

There will be no direct impact on the AlayaCare software functionality or existing roadmap commitments as a result of the acquisition. Bringing Delta Health’s team and solution onboard will enhance AlayaCare’s mission to bridge the gap between home health and home care through more interoperable, best-of-breed solutions across the continuum. Through this acquisition, AlayaCare gains 100+ new customers and more than 45 new employees who will help provide a foundation and blueprint for AlayaCare’s ongoing product development into the home health and hospice sectors.